Efficacy and safety of tadalafil across ethnic groups and various risk factors in men with erectile dysfunction: Use of a novel noninferiority study design.

Efficacy and safety of tadalafil across ethnic groups and various risk factors in men with erectile dysfunction: Use of a novel noninferiority study design.

Item
http://www.wikidata.org/entity/Q42685235
Management of sexual dysfunction due to central nervous system disorders: a systematic reviewSexual health outcome measures for individuals with a spinal cord injury: a systematic review.A meta-regression evaluating the effectiveness and prognostic factors of oral phosphodiesterase type 5 inhibitors for the treatment of erectile dysfunction.Efficacy and safety of tadalafil taken as needed for the treatment of erectile dysfunction in Asian men: results of an integrated analysis.Measurement of sexual functioning after spinal cord injury: preferred instruments.Relationship between erectile function and sexual self-confidence: a path analytic model in men being treated with tadalafil.Retrospective analysis of the efficacy and safety of once-daily tadalafil in patient subgroups: men with mild vs moderate ED and aged <50 vs 50 years.Daily patterns of sexual intercourse attempts by men with erectile dysfunction treated with tadalafil: influence of age and marital status.Response to treatment with tadalafil in men with erectile dysfunction who reported no successful intercourse attempts at baseline.
P2860

Efficacy and safety of tadalafil across ethnic groups and various risk factors in men with erectile dysfunction: Use of a novel noninferiority study design.

Item
http://www.wikidata.org/entity/Q42685235
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Efficacy and safety of tadalaf ...... l noninferiority study design.
@en
Efficacy and safety of tadalaf ...... l noninferiority study design.
@nl
type
label
Efficacy and safety of tadalaf ...... l noninferiority study design.
@en
Efficacy and safety of tadalaf ...... l noninferiority study design.
@nl
prefLabel
Efficacy and safety of tadalaf ...... l noninferiority study design.
@en
Efficacy and safety of tadalaf ...... l noninferiority study design.
@nl
P1433
P1476
P2093
P304
P31
P356
P433
P478
P50
P577
P698
P356
P1433
P1476
Efficacy and safety of tadalaf ...... l noninferiority study design.
@en
P2093
P304
P31
P356
10.1111/J.1743-6109.2006.00209.X
P433
P478
P50
P577
P698